Skip to Content
Merck
CN
  • [Use of nicotinic acid and midocalm for correcting blood coagulation in patients with radiation edema of the extremities].

[Use of nicotinic acid and midocalm for correcting blood coagulation in patients with radiation edema of the extremities].

Meditsinskaia radiologiia (1985-08-01)
S I Chekalina, L I Guseva, M S Bardyechev
ABSTRACT

A study was made of the functional activity of platelets, plasmatic coagulation and fibrinolysis in patients with late radiation disorders of the blood and lymph flow during treatment with vasodilative drugs: nicotinic acid and midocalm. These drugs tend to decrease the functional activity of platelets and to raise the blood fibrinolytic activity. Their use is indicated to this group of patients to better their intravascular status.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Nicotinic acid, meets USP testing specifications
Sigma-Aldrich
Nicotinic acid, ≥98%
Sigma-Aldrich
Nicotinic acid, ≥99.5% (HPLC)
Supelco
Nicotinic acid, analytical standard
Supelco
Niacin (Nicotinic Acid), Pharmaceutical Secondary Standard; Certified Reference Material